Why Journalists Won’t Investigate the Trans Medical Industry -Gerald Posner (#15)
Gerald Posner — Pulitzer Prize finalist, former trial lawyer, and veteran pharmaceutical investigator — applies the forensic lens he trained on the opioid crisis to the expansion of gender medicine for young people. His argument is structural rather than ideological: when commercial incentives align with regulatory loopholes and professional conformity, patients suffer. For European listeners watching Sweden, Finland, France and the Netherlands reassess their own clinical guidelines, his account of how this happened in plain sight offers a framework the mainstream press has been reluctant to supply.
Gerald Posner arrives on Beyond Gender with credentials that are difficult to dismiss. A Pulitzer Prize finalist, former trial lawyer, and the journalist who spent years investigating the pharmaceutical industry's role in the American opioid catastrophe, he now turns that same investigative method toward gender medicine — and what he finds will be familiar to anyone who has watched a public health scandal develop in slow motion. His central argument is structural rather than ideological: when commercial incentives, regulatory gaps, and professional groupthink converge, patients pay the price regardless of how compassionate the surrounding rhetoric sounds. The conversation moves from the mechanics of pharmaceutical marketing to the specific regulatory loopholes that have allowed puberty blockers and cross-sex hormones to be prescribed to children and adolescents with limited long-term evidence. In the United States, off-label prescribing rules create a space where a drug approved for one condition — precocious puberty in the case of GnRH analogues — can be used for another with minimal additional scrutiny. Posner frames this not as conspiracy but as the entirely predictable outcome of a system designed around commercial incentives, and one that investigative journalists should have been interrogating for years. That journalism has largely failed to do so is, for him, part of the same story. He describes the pressures — social, institutional, and financial — that have led major outlets to treat gender medicine as a protected topic. Editors who might once have commissioned the investigation now hesitate; publishers have gone quiet. The result is a persistent gap between what clinical researchers know and what a general European audience encounters in its newspapers or on its public broadcasters. For listeners in Germany, France, or the Netherlands, where comparable editorial caution has been widely observed, the dynamic he describes will feel recognisable. What gives the episode particular weight for a European audience is the contrast it illuminates between the United States — where pharmaceutical commercial pressures have been most acute — and the Nordic countries, where systematic evidence reviews have led to formal policy reversals. Sweden and Finland have each restricted the use of puberty blockers and cross-sex hormones for minors after concluding that the evidence base was insufficient to support routine clinical use. France's national health authority has reached comparable conclusions. The Dutch protocol, developed at Amsterdam's gender clinic and long considered the international template for the field, is itself under renewed scrutiny. Posner's account of how pharmaceutical interest shapes clinical practice and discourages internal dissent helps explain why these reversals have come from regulators and systematic reviewers rather than from journalists. WPATH, the body whose published standards of care underpin clinical practice across European gender clinics, appears in the episode through the lens of its leaked internal communications. Posner reads these as evidence of political calculation being placed ahead of scientific rigour. For European clinicians and policymakers who have cited WPATH guidelines as the evidential foundation for clinical decisions, the questions he raises about institutional capture are not abstract. They concern the assumptions on which practice has rested — and whether those assumptions were ever as secure as they were presented to be.
